لخّصلي

Therapeutic Plan:

Device Selection.1 : Utilize wearable insulin delivery systems such as the Omnipod 5 Automated Insulin Delivery System or Medtronic's MiniMed systems.Intervention: Compare the wearable insulin delivery system with standard care (e.g., continuous subcutaneous insulin infusion [CSII] or multiple daily injections [MDI]).These devices integrate continuous glucose monitoring (CGM) data to adjust insulin delivery automatically.2.Patient Eligibility Include patients aged years and older with Type 1 Diabetes (T1D), focusing on both adults and children to assess efficacy across different age groups.- Time in Range (TIR): The percentage of time blood glucose levels are within the target range (70-180 mg/dL

?Hemoglobin A1c (HbA1c) Levels: To assess overall glycemic control

?Monitoring Parameters Track key outcomes such as:

?3.4.5.

Therapeutic Plan:

Device Selection.1
: Utilize wearable insulin delivery systems such as the Omnipod 5 Automated Insulin Delivery System or Medtronic's MiniMed systems. These devices integrate continuous glucose monitoring (CGM) data to adjust insulin delivery automatically.

2.Patient Eligibility
Include patients aged
years and older with Type 1 Diabetes (T1D), focusing on both adults and children to assess efficacy across different age groups.

3. 
   

   Study Duration
   : Conduct studies over a period of several months to a year to capture long-term effects and adaptability of the system.

   
   


4. 
   

   Monitoring Parameters
   Track key outcomes such as:

   
   

● - Time in Range (TIR):
The percentage of time blood glucose levels are within the target range (70-180 mg/dL

● Hemoglobin A1c (HbA1c) Levels:
To assess overall glycemic control

● Hypoglycemia Incidence: Episodes of blood glucose below 70 mg/dL

● -:Patient Satisfaction and Quality of Life Through surveys and questionnaires.

5. Intervention: Compare the wearable insulin
   delivery system with standard care (e.g., continuous subcutaneous insulin infusion [CSII] or multiple daily injections [MDI]).